[1]ChemicalandPharmaceuticalBulletin,1998,vol.46,#4,p.581-586
[1]OrganicLetters,2006,vol.8,#24,p.5441-5443
[2]Tetrahedron,2012,vol.68,#26,p.5172-5178
[3]JournaloftheAmericanChemicalSociety,2012,vol.134,#44,p.18245-18248
[4]Tetrahedron,2018,vol.74,#16,p.2020-2029
[1]JournaloftheChemicalSociety,PerkinTransactions1:OrganicandBio-OrganicChemistry(1972-1999),2000,vol.4,p.567-570
[2]BioorganicandMedicinalChemistry,2012,vol.20,#9,p.2962-2970
[1]JournaloftheChemicalSociety,PerkinTransactions1:OrganicandBio-OrganicChemistry(1972-1999),1991,#12,p.3005-3008
[1]Patent:US2003/18193,2003,A1,
[1]JournalofOrganicChemistry,1940,vol.5,p.606,608
[1]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1942,vol.62,p.532;engl.Ref.S.169 Chem.Abstr.,1951,p.2861
[1]TetrahedronLetters,2018,vol.59,p.869-872
[2]Patent:US2012/225863,2012,A1.Locationinpatent:Page/Pagecolumn40-41
[3]MedicinalChemistryResearch,2012,vol.21,p.1313-1321
[4]Tetrahedron,2015,vol.71,p.9187-9195
[5]YakugakuZasshi/JournalofthePharmaceuticalSocietyofJapan,1954,vol.74,p.495 Chem.Abstr.,1955,p.8182
[6]BioorganicandMedicinalChemistry,2008,vol.16,p.276-283
[7]ArchivderPharmazie,2010,vol.343,p.353-359
[8]Lettersindrugdesignanddiscovery,2011,vol.8,p.717-724
[9]MedicinalChemistryResearch,2014,vol.23,p.1465-1473
[10]MedicinalChemistryResearch,2020,vol.29,p.1520-1535
[1]JournalofOrganicChemistry,1970,vol.35,p.3596-3600
[1]Heterocycles,1990,vol.31,p.23-26
[2]Patent:CN103483210,2016,B.Locationinpatent:Paragraph0052;0053;0054
[3]ChemicalCommunications,2012,vol.48,p.10514-10516,3
[4]ChemicalandPharmaceuticalBulletin,1993,vol.41,p.2003-2006
[5]AustralianJournalofChemistry,1982,vol.35,p.1469-1480
[6]Synthesis,2011,p.1375-1382
[7]BioorganicandMedicinalChemistryLetters,2007,vol.17,p.756-760
[8]GreenChemistry,2013,vol.15,p.3020-3026
[9]Tetrahedron,2012,vol.68,p.7400-7407
[10]JournaloftheAmericanChemicalSociety,1967,vol.89,p.5259-5265
[11]BioorganicandMedicinalChemistryLetters,1999,vol.9,p.1619-1624
[12]HelveticaChimicaActa,1973,vol.56,p.2460-2479
[13]BulletinoftheChemicalSocietyofJapan,1987,vol.60,p.1091-1096
[14]JournaloftheAmericanChemicalSociety,1977,vol.99,p.3059-3067
[15]CanadianJournalofChemistry,1974,vol.52,p.749-760
[16]JournaloftheAmericanChemicalSociety,2008,vol.130,p.5206-5215
[17]Patent:WO2011/20193,2011,A1.Locationinpatent:Page/Pagecolumn25
[18]Synthesis,2011,p.2935-2940
[19]JournalofOrganicChemistry,2014,vol.79,p.11988-12003
[20]Chemistry-AEuropeanJournal,2015,vol.21,p.2785-2788
[21]AngewandteChemie-InternationalEdition,2015,vol.54,p.11240-11244 Angew.Chem.,2015,vol.127,p.11392-11396,5
[22]BioorganicandMedicinalChemistryLetters,2017,vol.27,p.131-134
[23]BioorganicandMedicinalChemistry,2017,vol.25,p.3719-3735
[24]AngewandteChemie-InternationalEdition,2019,vol.58,p.9939-9943 Angew.Chem.,2019,vol.58,p.10044-10048,5
Title: Ester and carbamate ester derivatives of Biochanin A: synthesis and in vitro evaluation of estrogenic and antiproliferative activities.
Journal: Bioorganic & medicinal chemistry 20120501
Title: Evaluation of (R)-(-)-α-methoxy phenyl acetic acid as a chiral shift reagent for resolution and determination of R and S enantiomers of modafinil in bulk drugs and formulations by 1H NMR spectroscopy.
Journal: Chirality 20120401
Title: Biological evaluation of phenolic constituents from the trunk of Berberis koreana.
Journal: Bioorganic & medicinal chemistry letters 20110415
Title: 2-(3-Bromo-4-meth-oxy-phen-yl)acetic acid.
Journal: Acta crystallographica. Section E, Structure reports online 20100701
Title: Anticancer activity of dinuclear gallium(III) carboxylate complexes.
Journal: European journal of medicinal chemistry 20100201
Title: Characterization of pu-erh tea using chemical and metabolic profiling approaches.
Journal: Journal of agricultural and food chemistry 20090422
Title: Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
Journal: Anti-cancer drugs 20090101
Title: Study of the cytotoxic activity of di and triphenyltin(IV) carboxylate complexes.
Journal: Journal of inorganic biochemistry 20081201
Title: 1-(2-Hydr-oxy-3,4-dimethoxy-phen-yl)-2-(4-methoxy-phen-yl)ethanone.
Journal: Acta crystallographica. Section E, Structure reports online 20081201
Title: Lipophilic (hydroxy)phenylacetates by solvent-free lipase-catalyzed esterification and transesterification in vacuo.
Journal: Journal of agricultural and food chemistry 20080709
Title: Biotransformation of p-methoxyphenylacetonitrile into p-methoxyphenylacetic acid by resting cells of Bacillus subtilis.
Journal: Biotechnology and applied biochemistry 20080701
Title: 15N CIDNP investigations of the peroxynitric acid nitration of L-tyrosine and of related compounds.
Journal: Organic & biomolecular chemistry 20060221
Title: Effect of applied potential on arylmethyl films oxidatively grafted to carbon surfaces.
Journal: Langmuir : the ACS journal of surfaces and colloids 20051122
Title: Contribution of aldehyde oxidase, xanthine oxidase, and aldehyde dehydrogenase on the oxidation of aromatic aldehydes.
Journal: Chemical research in toxicology 20041001
Title: Development and substantiation of a liquid chromatographic method for monitoring organic reactions involved in synthesis of 4-methoxyphenylacetic acid.
Journal: Journal of chromatography. A 20021004
Title: Fine structural specificity differences of trimethoprim allergenic determinants.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology 19961001
Title: Xiang C, et al. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer. Int J Biol Markers. 2018 Aug;33(3):314-320.